Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10137-10149
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10137
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10137
Figure 3 Cathepsin B mediated IGF-1-induced tumor growth and metastasis in diabetic mice.
A: Hepa 1-6 cells grew faster in diabetic mice than in normal mice. In total, 2 × 106 Hepa 1-6 cells were injected s.c. into the backs of mice. The data are presented as quantified tumor weights (mean volumes ± SE); B: Metastasis developed rapidly in diabetic mice. In total, 3 × 106 Hepa 1-6 cells were injected into the lateral tail vein of each mouse. The data are presented as representative bioluminescence images of lungs and metastatic nodule numbers in the lungs (mean ± SE); C: Hepa 1-6 cells expressing control shRNA or CTSB shRNA1 (2 × 106) were injected sc into the backs of the mice. The data are presented as the mean volumes ± SEM at the indicated time points; D: Hepa 1-6 cells expressing control shRNA or CTSB shRNA1 (3 × 106) were injected into the lateral tail vein of each mouse. The data are presented as the number of metastatic nodules in the lungs (mean ± SE). bP < 0.01; cP < 0.001 vs control.
-
Citation: Lei T, Ling X. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma
via the inhibition of proteasome-mediated cathepsin B degradation. World J Gastroenterol 2015; 21(35): 10137-10149 - URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10137.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10137